:

Sophie Rees1, Andrew Cooklin2, Callum Duncan3

  • 1Bristol Trials Centre, Bristol University, Bristol, BS8 1NU, UK.

NIHR open research
|October 8, 2025
PubMed
概括

患者和临床医生优先比较慢性偏头痛的CGRP MAbs和OnabotulinumtoxinA. 研究还应该关注Candesartan或Flunarizine与安慰剂的对比,以指导未来的治疗试验.